- Category
- Micro (2021-22)
- Udyam number
- UDYAM-AP-09-0002011

Infinix Pharmaceuticals Private Limited
About Infinix Pharmaceuticals Private Limited
Data last updated:
Infinix Pharmaceuticals Private Limited is a private limited company based in Srikakulam, Andhra Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 10 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U51909AP2021PTC117637.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santhosh Kumar Kuna and Kalpana Kuna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No.2 – 189 Venkatapuram Etcherla Mandalam, Srikakulam, Andhra Pradesh, India – 532402.
Infinix Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-09-0002011).
Company details
Recognitions & Rankings of Infinix Pharmaceuticals
Contact details
Infinix Pharmaceuticals Private Limited's registered office is in Srikakulam, Andhra Pradesh.
- Registered AddressD.No.2 – 189 Venkatapuram Etcherla Mandalam, Srikakulam, Andhra Pradesh, India – 532402
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Infinix Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Infinix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Infinix Pharmaceuticals Private Limited
Infinix Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santhosh Kumar Kuna | Director | 10 Mar 2021 | 5 Years 7 Months | Current |
| Kalpana Kuna | Director | 10 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Infinix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Infinix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Infinix Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Infinix Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Kalpana Kuna was appointed as Director on 10 Mar 2021.
Frequently asked questions
Infinix Pharmaceuticals is an active private limited company based in Srikakulam, Andhra Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 10 March 2021 (5+ years old) and is registered under CIN U51909AP2021PTC117637.
Infinix Pharmaceuticals has 2 current directors:
- Santhosh Kumar Kuna - Director
- Kalpana Kuna - Director
The latest financial statements of Infinix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Infinix Pharmaceuticals is U51909AP2021PTC117637. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infinix Pharmaceuticals was incorporated on 10 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Vijayawada.
Kalpana Kuna was appointed as Director on 10 Mar 2021. Santhosh Kumar Kuna was appointed as Director on 10 Mar 2021.
Yes, Infinix Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-09-0002011).
The registered office of Infinix Pharmaceuticals is at D.No.2 – 189 Venkatapuram Etcherla Mandalam, Srikakulam, Andhra Pradesh, India – 532402.
Infinix Pharmaceuticals operates in the trading industry, in the specialty segment.
Infinix Pharmaceuticals can be reached at its registered office: D.No.2 – 189 Venkatapuram Etcherla Mandalam, Srikakulam, Andhra Pradesh, India – 532402.

